Distribution Sector Set For Consolidation

BMI believes China's pharmaceutical distribution sector is entering a period of intense consolidation due to new rules that limit the number of companies delivering drugs to community-level medical institutions. Through acquisitions, mergers and the formation of alliances, Chinese pharmaceutical distributors will realise synergies, streamline operations and generate higher profit margins.

To read the full article, please choose one of the following options: